Literature DB >> 27626616

A novel mutation in PIGW causes glycosylphosphatidylinositol deficiency without hyperphosphatasia.

Max Hogrebe1, Yoshiko Murakami2, Martin Wild3, Martina Ahlmann4, Saskia Biskup5, Konstanze Hörtnagel5, Marianne Grüneberg1, Janine Reunert1, Tobias Linden6, Taroh Kinoshita2, Thorsten Marquardt1.   

Abstract

In recent years, many mutations have been identified that affect the biosynthesis of the glycosylphosphatidylinositol anchor, a biomolecule that attaches surface molecules to cell membranes. Here, we present two second-degree cousins with unexplained patterns of seizures. Next-generation sequencing identified the homozygous c.460A>G; p.(R154G) PIGW mutation in both patients. Transfection of the mutated allele into Pigw-defective CHO cells indicated impaired enzymatic activity of the mutated PIGW product. Alkaline phosphatase did not exceed the upper normal range and flow cytometry of CD16, CD24, and CD66c on granulocytes showed subtle changes of the cellular expression of the glycosylphosphatidylinositol-anchored proteins. The patients' phenotype is therefore remarkably different from the phenotype of the only other described individual with PIGW mutations. Patients might therefore be missed when relying on traditional flow cytometry of glycosylphosphatidylinositol-anchored proteins only and we suggest that glycosylphosphatidylinositol-deficiency should be considered even with patients not showing the typical clinical phenotypes.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  GPI anchor; PIGW; congenital disorders of glycosylation; hyperphosphatasia; inherited GPI deficiency; seizures

Mesh:

Substances:

Year:  2016        PMID: 27626616     DOI: 10.1002/ajmg.a.37950

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  What is new in CDG?

Authors:  Jaak Jaeken; Romain Péanne
Journal:  J Inherit Metab Dis       Date:  2017-05-08       Impact factor: 4.982

2.  Characterization of glycosylphosphatidylinositol biosynthesis defects by clinical features, flow cytometry, and automated image analysis.

Authors:  Alexej Knaus; Jean Tori Pantel; Manuela Pendziwiat; Nurulhuda Hajjir; Max Zhao; Tzung-Chien Hsieh; Max Schubach; Yaron Gurovich; Nicole Fleischer; Marten Jäger; Sebastian Köhler; Hiltrud Muhle; Christian Korff; Rikke S Møller; Allan Bayat; Patrick Calvas; Nicolas Chassaing; Hannah Warren; Steven Skinner; Raymond Louie; Christina Evers; Marc Bohn; Hans-Jürgen Christen; Myrthe van den Born; Ewa Obersztyn; Agnieszka Charzewska; Milda Endziniene; Fanny Kortüm; Natasha Brown; Peter N Robinson; Helenius J Schelhaas; Yvonne Weber; Ingo Helbig; Stefan Mundlos; Denise Horn; Peter M Krawitz
Journal:  Genome Med       Date:  2018-01-09       Impact factor: 11.117

3.  A novel PGAP3 mutation in a Croatian boy with brachytelephalangy and a thin corpus callosum.

Authors:  Tomohiro Sakaguchi; Tamara Žigman; Danijela Petković Ramadža; Lana Omerza; Silvija Pušeljić; Zrinka Ereš Hrvaćanin; Noriko Miyake; Naomichi Matsumoto; Ivo Barić
Journal:  Hum Genome Var       Date:  2018-03-08

4.  Mutations in the PIGW gene associated with hyperphosphatasia and mental retardation syndrome: a case report.

Authors:  Li'na Fu; Yan Liu; Yu Chen; Yi Yuan; Wei Wei
Journal:  BMC Pediatr       Date:  2019-02-27       Impact factor: 2.125

Review 5.  The Glycosylphosphatidylinositol biosynthesis pathway in human diseases.

Authors:  Tenghui Wu; Fei Yin; Shiqi Guang; Fang He; Li Yang; Jing Peng
Journal:  Orphanet J Rare Dis       Date:  2020-05-28       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.